Efficacy of Rytigynia senegalensis Blume on Free Radical Scavenging, Inhibition of α-Amylase and α-Glucosidase Activity, and Blood Glucose Level

Maidadi, Barthelemy; Ntchapda, Fidèle; Miaffo, David; Kamgue Guessom, Oulianovie

doi:https://doi.org/10.1155/2022/9519743

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 9519743 | https://doi.org/10.1155/2022/9519743

Efficacy of Rytigynia senegalensis Blume on Free Radical Scavenging, Inhibition of α-Amylase and α-Glucosidase Activity, and Blood Glucose Level

Barthelemy Maidadi,¹Fidèle Ntchapda,²David Miaffo,³and Oulianovie Kamgue Guessom⁴

Academic Editor: Rajeev K Singla

Received27 Jun 2022

Revised21 Aug 2022

Accepted27 Aug 2022

Published27 Sept 2022

Abstract

Rytigynia senegalensis (Rubiaceae) is a plant used in African medicine for the treatment of diabetes. The aim of this study was to evaluate the in vitro antioxidant, enzyme inhibitory, and hypoglycemic effects of Rytigynia senegalensis extract (RSE). The contents of phenols, tannins, and flavonoids were determined by phytochemical screening. 2,2-Azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) and 2,2-diphenylpicrylhydrazyl (DPPH) were determined to evaluate the free radical scavenging capacity of the RSE. The inhibitory activity of α-amylase and α-glucosidase was evaluated in vitro using the α-amylase and α-glucosidase inhibition methods and in vivo using the sucrose and starch tolerance tests. The glucose tolerance test was performed on normal rats using doses of 50, 100, and 200 mg/kg of RSE. RSE contains total phenols (36.35 mg GAE/g of extract), flavonoids (11.91 mg QE/g of extract), and tannins (13.01 mg CE/g of extract). RSE exhibits significant radical scavenging activity on DPPH and ABTS radicals with an IC₅₀ of 17.51 and 21.89 μg/mL, respectively. RSE showed an inhibitory effect on the activity of α-amylase and α-glucosidase with an IC₅₀ of 308.93 and 354.13 μg/mL, respectively. RSE (100 and 200 mg/kg) caused a significant decrease in area under the curve and postprandial glycemia at 60, 90, and 120 min following the administration of starch or sucrose. Regarding the glucose tolerance test, RSE (100 and 200 mg/kg) significantly reduced postprandial hyperglycemia from the 90th min posttreatment. RSE lowered postprandial hyperglycemia and has antioxidant properties. These effects would be due to the presence of bioactive compounds in the RSE.

1. Introduction

Diabetes mellitus is a metabolic disease responsible for major public health problems [1]. This disease is characterized by chronic hyperglycemia linked to a deficiency in either the secretion or the action of insulin, or both [2]. Globally, 463 million people have diabetes [3]. Predictions estimate that this prevalence will be around 550 million in 2025 and 642 million in 2040 [3]. Regarding type 2 diabetes, targeting enzymes involved in processing dietary carbohydrates in the intestinal tract is among the vital targets. Among these, α-amylase and α-glucosidase enzymes are of high pharmacological interest and are used to control elevated glucose level in type 2 diabetes mellitus [4]. For instance, α-amylase and α-glucosidase enzymes are responsible for the breakdown of starch and oligosaccharides to glucose and their inhibition plays a significant role to decrease the absorption of glucose in the intestine [5]. Long-chain carbohydrates are broken down into glucose by alpha-amylase enzyme, whereas α-glucosidase is responsible for the breakdown of disaccharides and starch into simpler monosaccharide glucose, resulting in hyperglycemia [6]. Untreated or poorly treated diabetes can lead to complications in blood vessels and thereby lead to cardiovascular disease, blindness, and kidney failure [7].

Some pharmaceutical treatments decrease the impact of the disease and its complications. The aim of these treatments is to reduce hyperglycemia by activating the endogenous secretion of insulin with sulphonylureas and glitinides or by improving the sensitivity of target tissues to insulin with thiazolidinediones and biguanides [8]. Other drugs such as miglitol and acarbose have inhibitory effects on the activity of α-amylase and α-glucosidase enzymes, mainly indicated in postprandial hyperglycemia. They can be used as monotherapy or in addition to insulin and other oral antidiabetic drugs [9]. Regardless of how they are administered, these medicines have harmful side effects such as gas, digestive pain, and diarrhea. In addition, they are contraindicated in patients at risk whose digestive system is too fragile to adapt to the disturbance caused by their mechanism of action. Given all of these limitations, more than 80% of the population resort to traditional medicine to treat common illnesses [10]. The use of medicinal plants and natural products is still a major source of therapy in the developing countries [11, 12]. The discovery of modern analytical techniques has further eased the process of ethnomedicinal drug discovery to identify, isolate, and characterize target molecules [13, 14]. Approximately more than four hundred plants are identified as having antidiabetic potential, but only a few of these plants have received medical and scientific evaluation [15]. A large number of α-amylase and α-glucosidase inhibitors are produced by different microorganisms and plants to regulate the activities of these enzymes [16]. The natural α-glucosidase inhibitors from plant sources, whose α-glucosidase inhibitory activities have been reported previously, include alkaloids, flavonoids, anthocyanins, terpenoids, curcuminoids, and phenolic compounds [17]. For instance, anthocyanins isolated from Pharbitis nil L. and Ipomoea batatas L. significantly reduce postprandial hyperglycemia via inhibition ofα glucosidase enzyme [18].

Hyperglycemia is often accompanied by the accumulation of free radicals, which contributes to severe complications in diabetics [19]. Herbs with both antihyperglycemic and anti-free radical properties may be beneficial in the management of diabetes mellitus and its complications. R. senegalensis Blume is a glabrous shrub with slender branchlets, more or less scrambling, with elegant foliage; flowers are white or greenish, paired on slender axillary peduncles, with reflexed petals. It is a plant of the Rubiaceae family, found in Africa in the Sahelian areas, and used empirically to treat hemorrhoids, constipation, pain during childbirth, hypertension, dysentery, and diabetes [20]. To the best of our knowledge, no previous study has been done on its antidiabetic and anti-free radical properties. The aim of this study was therefore to evaluate the anti-free radical and antihyperglycemic potential of RSE.

2. Materials and Methods

2.1. Chemicals

Acarbose, α-glucosidase, α-amylase, 3,5-dinitrosalicyclic acid, and p-nitrophenyl-α-D-glucopyranoside were purchased from Sigma-Aldrich, Saint, USA. Amidon, D-glucose, and sucrose were purchased from EduLab Biology Kit, Bexwell, Norfolk, PE38 9 GA, UK. These drugs and chemicals were obtained commercially in analytical grade.

2.2. Animal Material

The animal used consisted of male rats of the Wistar strain, aged between 10 and 12 weeks and weighing between 220 and 250 g. These rats were provided by the Laboratory of Medicinal Plants, Health and Galenic Formulation of the Faculty of Sciences of the University of Ngaoundéré (Cameroon) in polystyrene cages under conditions of ambient temperature (25 ± 2°C) and natural light (12 h light-dark cycle). Food and drinking water were given ad libitum for the duration of the experiment. The animals were acclimatized under laboratory conditions for 14 days before the various tests. Experimental animals were treated according to the Cameroon National Ethics Committee (Ref. no. FWIRB 00001954), and all experiments were reviewed and approved.

2.3. Plant Material

R. senegalensis was collected in the locality of Pette, a village located about 70 km of Maroua, Cameroon. A sample of it was identified by the botanist Dr. Todou Gilbert and kept at the National Herbarium of Cameroon under number 4496/SRFK. The harvested plant was washed with tap water, dried in the shade at room temperature, and then reduced to a fine powder.

2.4. Preparation of the Extract

A mass of 14.28 g of powder of R. senegalensis was introduced into 500 mL of distilled water previously brought to the boil for 30 min. After cooling, the solution was filtered through Whatman No. 1 paper. The filtrate obtained was evaporated in an oven at 45°C for 48 h, which allowed us to obtain 1.01 g of crude extract, i.e., a yield of 7.07%.

2.5. Qualitative Phytochemical Screening

Qualitative phytochemical tests were carried out according to the method described by Gilbert and Pratley [21].

2.5.1. Test for Tannins

The appearance of bluish-green coloration on the addition of 2 mL of RSE (1 mg/mL) to 3–4 drops of ferric chloride solution (5%) indicated the presence of tannins.

2.5.2. Tests for Phenols

RSE (2 mL) was prepared and then 5% of ferric chloride solution is added. The presence of phenols in the RSE is marked by the appearance of the dark green color.

2.5.3. Tests for Flavonoids

The existence of the flavonoids was confirmed by the appearance of pink color after a few minutes when small pieces of magnesium ribbon and concentrated HCl were combined with RSE.

2.5.4. Test for Saponins

RSE (1 mL), distilled water (5.0 mL), and a few drops of oil were mixed in a test tube and vigorously shaken. The appearance of a foam of about 1 cm indicated the presence of saponins in the RSE.

2.5.5. Test for Quinones

A small amount of RSE was treated with concentrated HCL and observed for the formation of yellow precipitation (or coloration).

2.5.6. Test for Terpenoids

The terpenoids were indicated via gray color formation when 2 mL of chloroform was added with the 5 mL of RSE, and then, 3 mL of H₂SO₄ concentrated was added and boiled.

2.5.7. Test for Steroids

5 mL of RSE was added with 2 mL of H₂SO₄ concentrated and chloroform. The appearance of red color marks the presence of steroids in the RSE.

2.5.8. Test for Alkaloids

RSE was dissolved in dilute hydrochloric acid and filtered. The presence of alkaloids was confirmed by a yellow-colored precipitate when filtrates of RSE were treated with potassium mercuric iodide (Mayer’s reagent).

2.5.9. Tests for Glycosides

RSE was added with 2 ml of acetic acid and 2 mL of chloroform. The mixture was then cooled, and H₂SO₄ concentrated was added. The appearance of the green color is proof of the presence of glycosides in the RSE.

2.6. Quantitative Phytochemical Screening

2.6.1. Total Phenol Content

A mixture of 0.5 mL of a gallic acid or RSE solution (0 to 100 μg/mL), 2.5 mL of the Folin-Ciocalteu reagent (10%), and 4 mL of sodium carbonate solution (7.5%, w/v) were incubated for 30 min at room temperature [22]. The absorbance of the mixture was read at a wavelength of 727 nm. The total phenol content of the sample was expressed in milligrams of gallic acid equivalents per gram (mg GAE/g) of dry extract.

2.6.2. Total Flavonoid Content

A mixture of 1 mL of quercetin or RSE solution (0 to 100 μg/mL), 0.2 mL of aluminum chloride solution (10% w/v), 0.2 mL of potassium acetate solution (1 M), and 5.6 mL of distilled water were incubated for 30 min at room temperature [23]. The absorbance of the mixture was read at a wavelength of 415 nm. The total flavonoid content of the sample was expressed in milligrams of quercetin equivalents per gram (mg QE/g) of dry extract.

2.6.3. Total Tannin Content

A mixture of 50 μL of catechin or RSE solution (0 to 100 μg/mL), 750 μL of chloride acid solution (12 M), and 1.5 mL of methanol solution (4%) were incubated for 20 min at room temperature [24]. The absorbance of the mixture was read at a wavelength of 500 nm. The total tannin content of the sample was expressed in milligrams of catechin equivalent per gram (mg CE/g) of dry extract.

2.7. Free Radical Scavenging Potential of RSE

2.7.1. Diphenyl-1-Picrylhydrazyl (DPPH) Radical Scavenging Activity

RSE solution (2.5 mL) at different concentrations (1–200 μg/mL) was mixed with 0.5 mL of freshly DPPH solution (0.2 mM in 1 mL of ethanol), and the mixture was vigorously vortexed at room temperature for 30 min [25]. RSE was replaced with distilled water in the control tubes, and the positive control used was Trolox. The absorbance of the mixture was read at a wavelength of 517 nm. The antiradical activity of the RSE was expressed as a percentage inhibition (I%) according to the following equation: I% = ((absorbance control − absorbance sample)/absorbance control) × 100. The amount of the sample necessary to decrease the absorbance of DPPH by 50% (IC₅₀) was calculated graphically.

2.7.2. 2,2-Azino-Bis-3-Ethylbenzothiazoline-6-Sulphonic Acid (ABTS) Radical Scavenging Assay

The method described by Re et al. [26] allowed us to determine the ABTS radical scavenging activity of RSE. The ABTS solution was prepared by mixing 5 mL of ABTS (7 mM) and 5 mL of potassium persulfate solution (2.4 mM) and allowed to react in the dark at room temperature for 12 h. Before use, ABTS⁺ solution (1 mL) was diluted with ethanol (60 mL) to an absorbance of 0.70 ± 0.05 at 734 nm. Afterward, 100 μL of RSE or butylhydroxyanisole at different concentrations (1–200 μg/mL) to 4 mL of diluted ABTS+ solution, absorbance was measured at 734 nm after 7 min. ABTS scavenging ability was expressed as IC₅₀ (l g/mL), and the inhibition percentage was calculated using the following formula: ABTS⁺ radical scavenging activity (I%) = ((absorbance control − absorbance sample)/absorbance control) × 100.

2.8. Digestive Enzyme Inhibitory Potential of RSE

2.8.1. In Vitro Inhibition Test of α-Amylase Activity

Briefly, 100 μL of RSE or acarbose solution (25, 50, 100, 200, and 300 μg/mL) and 100 μL of α-amylase solution (0.5 mg/mL in 0.20 mM sodium phosphate buffer, pH 6.9) were mixed and preincubated for 10 min at 25°C [4]. Afterward, 200 μL of 1% starch solution in 0.02 M sodium phosphate buffer (pH 6.9) was added to the mixture. After incubation at 37°C for 10 min, the reaction was stopped by the addition of 200 μL of 3,5-dinitrosalicylic acid reagent. The tubes were cooled at room temperature after incubating them in boiling water for 5 min. Then, 5 mL of distilled water was added to the reaction mixture and absorbance was measured at 540 nm. The inhibition activity was calculated as follows: % inhibition = ((Abs control − Abs sample)/Abs control) × 100, where Abs is absorbance. Control represents 100% enzyme activity and was conducted in a similar way by replacing RSE with distilled water. For the blank, the enzyme solution was replaced with distilled water. The inhibitory activity was expressed as the concentration of the RSE or acarbose resulting in 50% inhibition of the enzyme (IC₅₀) and calculated by regression analysis.

2.8.2. In Vitro Inhibition Test of α-Glucosidase Activity

The inhibitory effect of the RSE on the activity of the α-glucosidase enzyme was determined by the method described by Kim et al. [27]. Indeed, 50 μL of RSE or acarbose at different concentrations (25, 50, 100, 200, and 300 μg/mL) was introduced into 100 μL of Tris buffer (20 mM; pH 6.8) containing 100 μL of α-glucosidase solution (0.01 mg/mL) and preincubated at 25°C for 10 min. After preincubation, 50 μL of p-nitrophenyl-α-D-glucopyranoside (5 mM) was added to each tube to start the reaction and the mixture was again incubated at 37°C for 15 min. The reaction was stopped after adding 2 mL of Na₂CO₃ (500 mM) to each tube. The absorbance of the sample was read at 400 nm. The percent inhibition (I%) and the concentration of the RSE required to inhibit the activity of the enzyme by 50% (IC₅₀) were determined as in the test for inhibition of the activity of α-amylase enzyme.

2.8.3. In Vivo Inhibition Test of α-Amylase Activity (Starch Tolerance Test)

A starch tolerance test was performed in normal animals according to the method described by Miaffo et al. [28]. Here, 30 male rats fasted non-water for 16 hours were divided into 5 groups of 6 rats each and treated as follows: group 1 (control group) received distilled water (10 mL/kg); group 2 (reference group) treated with acarbose (10 mg/kg); groups 3, 4, and 5 received the RSE at doses of 50, 100, and 200 mg/kg, respectively. Ten minutes (10 min) after taking the initial blood sugar (t₀) followed by their treatment, each rat received orally 3 g/kg of the starch solution. On the 30th, 60th, 90th, and 120th minutes following the carbohydrate overload, the blood glucose level was measured with a glucometer and strips.

2.8.4. In Vivo Inhibition Test of α-Glucosidase Activity (Sucrose Tolerance Test)

The sucrose tolerance test was performed similarly to the starch tolerance test described above, with the only difference being that the sucrose solution was administered at a dose of 4 g/kg body weight [28].

2.9. Hypoglycemic Plus Antihyperglycemic Effects of RSE in Normal Rats

The hypoglycemic and antihyperglycemic effects of RSE were evaluated according to the method described by Kato and Miura [29] with slight modifications. Twenty-five (25) male rats were fasted for 14 hours and then divided into 5 groups of 5 rats each. The initial glycemia of the animals was evaluated in each group using a OneTouch UltraMini glucometer (Life Scan Europe, 6300 zug, Switzerland) and strips. Subsequently, the animals were treated with 10 mL/kg of distilled water (group 1), 3 mg/kg of glibenclamide (group 2), and doses of 50, 100, and 200 mg/kg of RSE (groups 3, 4, and 5, respectively). Blood glucose levels were taken at the 30th and 60th minutes posttreatment to assess the hypoglycemic effect of RSE.

Ninety minutes (90 min) after the various treatments mentioned above, the blood sugar levels of the animals were taken again. Immediately, the rats were force-fed with a solution of D-glucose (3 g/kg) and the glycemia was evaluated at times 120, 150, 180, and 210 minutes to evaluate the antihyperglycemic effect of RSE.

2.10. Statistical Analysis

All results were expressed as the mean ± standard derivation. The data obtained were analyzed using GraphPad Prism version 5.0 software. Two-way analysis of variance and Bonferroni’s posttest were used for the treatment of double-variable tests. In contrast, one-way analysis of variance and Tukey’s posttest were used to analyze data from the single-variable tests. Statistical significance was considered at .

3. Results

3.1. Qualitative Phytochemical Screening

The qualitative phytochemical study reveals the presence in RSE of bioactive compounds such as tannins, phenols, flavonoids, saponins, quinones, terpenoids, and glycosides and the absence of alkaloids, and steroids (Table 1).

3.2. Quantitative Phytochemical Screening

The result of the quantitative phytochemistry is shown in Table 2. We find all the classes of chemical compounds demonstrated in RSE but in different amounts. Indeed, RSE contains 36.35 ± 1.06 mg GAE/g of dry extract of total phenols, 11.91 ± 0.15 mg QE/g of dry extract of total flavonoids, and 13.01 ± 0.24 mg CE/g of dry extract of total tannins. There are more total phenols in the RSE than the total flavonoids and tannins.

3.3. Free Radical Scavenging Potential of RSE

The anti-free radical activity of RSE is shown in Tables 3 and 4. It appears that the RSE has a lower DPPH scavenging activity (IC₅₀ = 17.51 ± 0.68 μg/mL) than that of Trolox (IC₅₀ = 22.48 ± 0.16 μg/mL) (Table 3). In addition, the anti-free radical ABTS activity of the RSE (IC₅₀ = 21.89 ± 0.39 μg/mL) was also lower than that of BHA (IC₅₀ = 23.05 ± 0.77 μg/mL) (Table 4).

3.4. Inhibitory Effects of RSE on the α-Amylase Activity

Figure 1 shows the inhibitory effect of RSE on the α-amylase activity. Observations reveal a gradual change in the percentage inhibition depending on the concentration. In fact, acarbose showed significant inhibitory potential with inhibition percentages varying between 33.29% and 70.60%, corresponding to concentrations ranging from 25 to 300 μg / mL, i.e., an average inhibitory concentration (IC₅₀) of 69.47 μg /mL (Table 5). RSE, for its part, showed inhibitory activity of 6.15% and 48.36% for respective concentrations of 25 and 300 μg/mL, i.e., an IC₅₀ of 308.83 μg/mL (Table 6).

3.5. Inhibitory Effect of RSE on the α-Glucosidase Activity

Figure 2 shows the inhibitory effect of RSE on the activity of the α-glucosidase enzyme. Acarbose caused a strong inhibition of α-glucosidase activity with percentages of 11.48 and 53.77 for the respective concentrations of 25 and 300 μg/mL, i.e., an IC₅₀ of 284.23 μg/mL (Table 5). Likewise, RSE also has significant inhibitory potential on α-glucosidase activity. This inhibition varies from 7.56% to 50.29% for concentrations ranging from 25 to 300 μg/mL, i.e., an IC₅₀ of 354.13 μg/mL (Table 6).

3.6. Effects of RSE during the Starch Tolerance Test

Figure 3 shows the results of the starch tolerance test in rats with temporary hyperglycemia treated with different doses of RSE. It can be seen from this figure that the blood glucose levels of all the animals increased at the 30th min and then gradually decreased until the end of the experiment. However, the blood glucose levels of the animals treated with acarbose and the various doses of RSE remained lower than that of the rats in the control group. Compared with animals in the control group, acarbose caused a significant drop () in blood glucose levels at the 60th, 90th, and 120th minutes. Likewise, 200 mg/kg dose of RSE caused a significant reduction in blood glucose levels at the 60 (), 90 (), and 120th min () posttreatment. A significant decrease in blood glucose level was also noted at the 60 (), 90 (), and 120th min () with the dose of 100 mg/kg of RSE.

(a)

(b)

Compared with rats in the control group, acarbose resulted in a significant () reduction in AUC. Furthermore, only the 100 mg/kg dose of RSE also caused a significant decrease () in AUC (Figure 3).

3.7. Effects of RSE during the Sucrose Tolerance Test

RSE and acarbose lowered postprandial blood glucose levels at all time slots, compared with the control group (Figure 4). In fact, there is a significant decrease ( to ) in blood glucose levels at the 30, 60, 90, and 120th minutes after administration of acarbose and RSE at doses of 100 and 200 mg/kg, compared with the control group. Moreover, at the dose of 50 mg/kg of RSE, the decrease () in blood glucose was observed rather at the 60th, 90th, and 120th minutes.

(a)

(b)

Both acarbose and RSE at doses of 100 and 200 mg/kg induced a significant () decrease in AUC, compared with the control group (Figure 4). This decrease was less significant () with the dose of 50 mg/kg of RSE.

3.8. Hypoglycemic Plus Antihyperglycemic Effects of RSE

The effects of the different treatments on baseline glycemia plus oral-induced hyperglycemia in normal rats are shown in Table 7. It appears from this table that no significant change in glycemia was noted at the 30th, 60th, and 90th minutes after administration of RSE at all doses, compared with the control group. On the other hand, a significant fall () in the blood glucose level was noted in the rats having received glibenclamide at the 60th and 90th minutes.

In addition, 90 minutes after the carbohydrate overload, blood sugar levels fell significantly () with glibenclamide from the 120th to the 180th minutes, compared with the control group. Similarly, at the 150th and 180th minutes, the administration of RSE at doses of 100 and 200 mg/kg resulted in a significant () drop in blood sugar level.

4. Discussion

Inhibiting the activity of α-amylase and α-glucosidase, enzymes involved in the digestion of carbohydrates, can significantly reduce the rise in postprandial blood glucose and therefore may be an important strategy in the management of blood sugar levels in type 2 diabetics [30]. Unfortunately, current treatments are limited only to poor control of the exacerbation, and in addition, there are various harmful side effects. However, natural inhibitors of α-amylase and α-glucosidase activity contained in various plants have fewer or no side effects [31]. α-Amylase enzymes hydrolyze complex polysaccharides to produce oligosaccharides and disaccharides, which are then hydrolyzed by α-glucosidase enzymes to monosaccharides, which are absorbed by the intestines [32]. α-Amylase and α-glucosidase enzyme inhibitors delay digestion and absorption of carbohydrates, thereby lowering postprandial glucose levels [33].

Medicinal plants and their fruits/seeds including cinnamon, aloe, gymnema, bitter melon, coffee, guava, cocoa, green tea, nettle, garlic, sage, caper, soybean, turmeric, yerba mate, and walnut have got tremendous focus and have scientifically proved antidiabetic potentials. Several isolated compounds from natural origin including phenolic, galegine, pycnogenol, miglitol, voglibose, and acarbose are extensively employed for the management of T2DM [34].

In vitro studies have shown the inhibitory effect of acarbose and RSE on the activity of α-amylase and α-glucosidase enzymes. Based on the IC₅₀ values, the inhibitory potency of the RSE was stronger on the α-amylase enzyme than on the α-glucosidase. Concentration-dependent inhibition was also observed with acarbose on both α-glucosidase enzyme activity and α-amylase enzyme activity. These results are similar to those of Mahamad et al. [35] who showed that the aqueous extract of Cissus polyantha has a strong inhibitory effect on the activity of α-amylase and α-glucosidase.

However, the inhibitory activity in vitro is not always linked to the corresponding in vivo activity. Thus, the results obtained in vitro must be proven in vivo studies. It is with this in mind that in vivo studies on starch and sucrose tolerance tests were carried out. Thus, in these studies, doses of 100 and 200 mg/kg of RSE produced a significant decrease in blood glucose levels at the 60, 90, and 120th minutes after administration of the starch. Likewise, 100 mg/kg dose significantly lowered AUC. For the sucrose tolerance test, all doses of the RSE significantly lowered AUC and blood glucose levels at the 60, 90, and 120th minutes. RSE appears to delay the rapid digestion of starch and sucrose to increase the duration of carbohydrate absorption and thereby lower postprandial hyperglycemia. Thus, RSE showed a significant inhibitory effect on both types of α-amylase and α-glucosidase enzymes in vitro and in vivo. These results suggested that the RSE could decrease postprandial glucose levels by inhibiting the activity of α-amylase and α-glucosidase, which are enzymes important in the digestion of carbohydrates [36]. Polyphenols and flavonoids from plants are known as natural antidiabetic agents having an inhibitory effect on the activity of digestive enzymes responsible for the hydrolysis of carbohydrates [37, 38]. Our results show the presence of total phenols (36.35 mg GAE/g of extract), flavonoids (11.91 mg QE/g of extract), and tannins (13.01 mg CE/g of extract). The presence of these compounds in the aqueous extract would be responsible for the antihyperglycemic effects in vitro and in vivo observed in the present work.

In this study, the ability of the RSE to donate hydrogen was verified using the radicals DPPH and ABTS. The amount of sample required to decrease the initial concentration of free radical by 50% is a parameter widely used to measure the anti-free radical activity of plant extracts. Indeed, the anti-free radical potential of the plant is inversely proportional to the average inhibitory concentration (IC₅₀). The results of our study showed significant radical scavenging activity on DPPH (IC₅₀ = 21.89 μg/mL) and ABTS (IC₅₀ = 14.65 μg/mL) radicals. Phenolic compounds have the ability to scavenge free radicals thanks to their hydroxyl groups [39]. They mainly act as reducing agents, hydrogen donors, singlet oxygen extinguishers, or metal chelators [40]. These different classes of chemical compounds present in RSE would be responsible for the anti-free radical potential observed in this study.

During the glucose tolerance test, glibenclamide and RSE (100 and 200 mg/kg) led to a significant reduction in postprandial hyperglycemia from the 120th minute, compared with the control group. Indeed, glibenclamide is a sulfonylurea antidiabetic that stimulates the secretion of insulin by binding to the protein (sulfonylurea) of the channels (K + -ATP) of the beta cells of the islets of Langerhans causing their depolarization with, as a consequence, an entry of the calcium in beta cells, responsible for the exocytosis of insulin storage granules [41]. RSE would have acted either by stimulating the secretion of insulin-like reference substance or by mimicking the effects of insulin at the level of its specific receptors or by decreasing gluconeogenesis and glycogenolysis or by increasing the use of glucose and glycolysis [42, 43]. The antihyperglycemic activity observed in this work would be due to a synergistic action of the bioactive compounds (phenols, flavonoids, and tannins) present in RSE.

5. Conclusion

RSE has anti-free radical and inhibitory properties on the activity of α-amylase and α-glucosidase enzymes and therefore reduces postprandial glycemia. These pharmacological effects would be due to the presence of bioactive compounds in the RSE. In future work, we will study different models of diabetes and its comorbidities to accurately confirm the antidiabetic properties of RSE.

Data Availability

The experimental data used to support the findings of this study can be obtained from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors are grateful to the Laboratory of Biological Sciences of the University of Ngaoundere (Cameroon) and the Laboratory of Life and Earth Sciences of the University of Maroua (Cameroon) for providing the facility to carry out the research.

Supplementary Materials

Supplementary Materials. Standard curves of gallic acid E/g extract, quercetin E/g extract, and catechin E/g extract. Figure 1. Standard curve of gallic acid. Figure 2. Standard curve of quercetin. Figure 3. Standard curve of catechin. (Supplementary Materials)

References

S. Rima and B. Mahmoud, “Anti-diabetic activity of different oils through their effect on arylsulfatases,” Journal of Diabetes and Metabolic Disorders, vol. 13, no. 1, p. 116, 2014.
View at: Google Scholar
S. T. Mohammad, M. Mahboubeh, and V. N. Tahereh, “Antidiabetic activity of hydroalcoholic extract of Myrtuscommunis (Myrtle) fruits in streptozotocin-induced and dexamethasone-induced diabetic rats,” Pharmacognosy Research, vol. 11, no. 2, p. 120, 2019.
View at: Google Scholar
IDF (International Diabetes Federation), DiabetesAtlas, IDF (International Diabetes Federation), Brussels, Belgium, 8th edition, 2019.
M. H. Mahnashi, Y. S. Alqahtani, B. A. Alyami et al., “Phytochemical analysis,α-glucosidase and amylase inhibitory, and molecular docking studies onPersicariahydropiper L. Leaves essential oils,” Evidence-Based Complementary and Alternative Medicine, vol. 2022, Article ID 7924171, 11 pages, 2022.
View at: Publisher Site | Google Scholar
H. Gin and V. Rigalleau, “Post-prandial hyperglycemia. Post-prandial hyperglycemia and diabetes,” Diabetes and Metabolism, vol. 26, no. 4, pp. 265–272, 2000.
View at: Google Scholar
S. S. Nair, V. Kavrekar, and A. Mishra, “In vitro studies on alpha-amylase and alpha- glucosidase inhibitory activities of selected plant extracts,” European Journal of Experimental Biology, vol. 3, no. 1, pp. 128–132, 2013.
View at: Google Scholar
R. Stockli and L. Zimmerli, “Hypertension and diabetes,” Forum Medical Suisse, vol. 9, no. 36, pp. 626–629, 2009.
View at: Google Scholar
O. Meriem, Validation des effets antidiabétiques de Rhododendron groenlandicum, une plante des Cri de la Baie James, dans le modèle in vitro et in vivo: Elucidation des mécanismes d’action et identification des composés actifs, Université de Montréal, Montréal, Canada, 2010.
S. Dagnoko, “Etude de la qualité des feuilles de Sclerocaryabirrea(a. rich) hoscht utilisées dans le traitement du diabète,” Université de Bamako Mali, Bamako, Mali, 2009, Doctoral thesis.
View at: Google Scholar
World Health Organization, Traditional Medicine Strategy, World Health Organization, Geneva, Switzerland, 2019.
M. Ayaz, F. Ullah, A. Sadiq, M. O. Kim, and T. Ali, “Editorial: natural products-based drugs: potential therapeutics against alzheimer’s disease and other neurological disorders,” Frontiers in Pharmacology, vol. 10, p. 1417, 2019.
View at: Publisher Site | Google Scholar
U. Saleem, R. Akhtar, F. Anwar et al., “Neuroprotective potential of Malvaneglecta is mediated via down-regulation of cholinesterase and modulation of oxidative stress markers,” Metabolic Brain Disease, vol. 36, no. 5, pp. 889–900, 2021.
View at: Publisher Site | Google Scholar
B. Petrovska, “Historical review of medicinal plants’ usage,” Pharmacognosy Reviews, vol. 6, no. 11, p. 1, 2012.
View at: Publisher Site | Google Scholar
U. Saleem, S. Khalid, S. Zaib et al., “Phytochemical analysis and wound healing studies on ethnomedicinally important plant MalvaneglectaWallr,” Journal of Ethnopharmacology, vol. 249, Article ID 112401, 2020.
View at: Publisher Site | Google Scholar
C. J. Bailey and C. Day, “Traditional plant medicines as treatments for diabetes,” Diabetes Care, vol. 12, no. 8, pp. 553–564, 1989.
View at: Publisher Site | Google Scholar
A. Choudhury, K. Maeda, R. Murayama, and E. DiMagno, “Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones,” Gastroenterology, vol. 111, no. 5, pp. 1313–1320, 1996.
View at: Publisher Site | Google Scholar
V. Kumar, O. Prakash, S. Kumar, and S. Narwal, “α-glucosidase inhibitors from plants: a natural approach to treat diabetes,” Pharmacognosy Reviews, vol. 5, no. 9, p. 19, 2011.
View at: Publisher Site | Google Scholar
T. Matsui, T. Ueda, T. Oki, K. Sugita, N. Terahara, and K. Matsumoto, “α-Glucosidase inhibitory action of natural acylated anthocyanins 1 survey of natural pigments with potent inhibitory activity,” Journal of Agricultural and Food Chemistry, vol. 49, no. 4, pp. 1948–1951, 2001.
View at: Publisher Site | Google Scholar
A. C. Maritim, R. A. Sanders, and J. B. Watkins, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003.
View at: Publisher Site | Google Scholar
H. Lantz and B. Bremer, “Phylogeny inferred from morphology and DNA data: characterizing well-supported groups in Vanguerieae (Rubiaceae),” Botanical Journal of the Linnean Society, vol. 146, no. 3, pp. 257–283, 2004.
View at: Publisher Site | Google Scholar
M. P. Gilbert and R. E. Pratley, “Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus,” TheAmerican Journalof Medicine, vol. 122, no. 6, pp. 11–24, 2009.
View at: Publisher Site | Google Scholar
V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventos, “Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent,” Methods in Enzymology, vol. 299, pp. 152–178, 1999.
View at: Google Scholar
I. Kosalec, M. Bakmaz, S. Pepeljnjak, and S. Vladimir-Knezevic, “Quantitative analysis of the flavonoids in raw propolis from northern Croatia,” ActaPharmaceuticavol, vol. 54, pp. 65–72, 2004.
View at: Google Scholar
F. Medini, H. Fellah, R. Ksouri, and C. Abdelly, “Total phenolic, flavonoid and tannin contents and antioxidant and antimicrobial activities of organic extracts of shoots of the plant Limonium delicatulum,” Journal of Taibah University for Science, vol. 8, no. 3, pp. 216–224, 2018.
View at: Publisher Site | Google Scholar
B. Huang, H. Ke, J. He, X. Ban, H. Zeng, and Y. Wang, “Extracts of Haleniaelliptica exhibit antioxidant properties in vitro and in vivo,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 185–190, 2011.
View at: Publisher Site | Google Scholar
R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology and Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999.
View at: Publisher Site | Google Scholar
J. S. Kim, C. S. Kwon, and K. H. Son, “Inhibition of α-glucosidase and amylase by Luteolin, a flavonoid,” Bioscience, Biotechnology, andBiochemistry, vol. 64, no. 11, pp. 2458–2461, 2000.
View at: Publisher Site | Google Scholar
D. Miaffo, S. L. Wansi, S. L. KamaniPoualeu, C. FofiéKueté, and A. Kamanyi, “In Vitroα-amylase and α-glucosidase enzymes inhibitory effects of the aqueous extract of combretummolle twigs,” International Journalof Toxicological and PharmacologicalResearch, vol. 7, no. 2, pp. 74–79, 2015.
View at: Google Scholar
A. Kato and T. Miura, “Hypoglycemic activity of Polygonatirhizoma in normal and diabetic mice,” Biological and Pharmaceutical Bulletin, vol. 16, no. 11, pp. 1118–1120, 1993.
View at: Publisher Site | Google Scholar
H. Bennacer, Effet Inhibiteur des Extraits de Zygophyllum geslinisur l’Activité d’Alpha-Amylase, Université Abou BekrBelkaid, Tlemcen Algerie, 2017.
R. Tundis, M. R. Loizzo, and F. Menichini, “Natural products as -Amylase and -Glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update,” Mini-ReviewsinMedicinal Chemistry, vol. 10, no. 4, pp. 315–331, 2010.
View at: Publisher Site | Google Scholar
C. Smith, A. D. Marks, and M. Lieberman, Mark’s Basic Medical Biochemistry: A Clinical Approach, Lipincott Williams and Wilkins, Baltimore, Maryland, 2nd Edition edition, 2005.
W. Puls, U. Keup, H. P. Krause, G. Thomas, and F. Hoffmeister, “Glucosidase inhibition: a new approach to the treatment of diabetes, obesity and hyperliproteinaemia,” Naturwissenschaften, vol. 64, no. 10, pp. 536-537, 1977.
View at: Publisher Site | Google Scholar
J. L. Rios, F. Francini, and G. R. Schinella, “Natural products for the treatment of type 2 diabetes mellitus,” Planta Medica, vol. 81, no. 12/13, pp. 975–994, 2015.
View at: Publisher Site | Google Scholar
M. A. Talba, D. Miaffo, S. L. Poualeu Kamani, A. Kamanyi, S. L. Wansi, and S. L. Wansi, “Antioxidant properties and digestive enzyme inhibitory activity of the aqueous extract from leafy stems of Cissus polyantha,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 7384532, 1 page, 2019.
View at: Publisher Site | Google Scholar
M. Gondwe, D. Kamadyaapa, M. Tufts, A. Chuturgoon, and C. Musabayane, “Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark ethanolic extract (SBE) modulates blood glucose, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) of STZ-induced diabetic rats,” Phytomedicine, vol. 15, no. 9, pp. 699–709, 2008.
View at: Publisher Site | Google Scholar
A. Béjaoui, A. Boulila, A. Sanaa, M. Boussaid, and X. Fernandez, “Antioxidant activity and α amylase inhibitory effect of polyphenolic-rich extract from OriganumglandulosumDesf,” Journal of Food Biochemistry, vol. 41, no. 1, Article ID e12271, 2016.
View at: Publisher Site | Google Scholar
J. Ahumada, C. Fuentealba, J. Olaeta et al., “Bioactive compounds of loquat (Eriobotrya japonicaLindl.) cv. Golden Nugget and analysis of in vitro functionality for hyperglycemia,” Ciencia E Investigacion, vol. 44, no. 3, pp. 272–284, 2017.
View at: Google Scholar
E. M. Wenzig, U. Widowitz, O. Kunert et al., “Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa caninal.) Preparations,” Phytomedicine, vol. 15, no. 10, pp. 826–835, 2008.
View at: Publisher Site | Google Scholar
N. Balasundram, K. Sundram, and S. Samman, “Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses,” Food Chemistry, vol. 99, no. 1, pp. 191–203, 2006.
View at: Publisher Site | Google Scholar
Y. Cheng and I. G. Funtus, “Oral antihyperglycemic therapy for type 2 diabetes mellitus,” Canadian Medical Association Journal, vol. 172, no. 2, pp. 213–226, 2005.
View at: Publisher Site | Google Scholar
L. Luzi and G. Pozza, “Glibenclamide: an old drug with a novel mechanism of action?” Acta Diabetologica, vol. 34, no. 4, pp. 239–244, 1997.
View at: Publisher Site | Google Scholar
M. Latha, L. Pari, S. Sitasawad, and R. Bhonde, “Insulinsecretagogue activity and cytoprotective role of the traditional antidiabetic plant Scopariadulcis(Sweet Broomweed),” Life Sciences, vol. 75, no. 16, pp. 2003–2014, 2004.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Barthelemy Maidadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

362

Downloads

279

Citations